Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its ...
UNIONDALE, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) is pleased to invite investors to a webinar on December 1, 2025, at 4:15 p.m. ET. A live question and answer session ...
ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations and ...
Garden City, NY, Feb. 06, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH) (“ProPhase”), a growth oriented and diversified diagnostics, genomics and biotech company, today provided an update ...
ProPhase Labs received a 180-day extension from Nasdaq to meet its $1.00 bid price compliance requirement. ProPhase Labs Inc. announced that it has received a 180-day extension from Nasdaq to meet the ...
In a challenging market environment, ProPhase Labs, Inc. (PRPH) stock has touched a 52-week low, reaching a price level of $1.99. This latest dip underscores a difficult period for the company, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results